Technology must make the Indian patent regime look sober & trustworthy to inventors
Novartis AG may be unhappy with the Indian patents’ regime
for refusing to grant patent rights to its cancer drug, Gilvec, but many others like the Swiss drug company, F. Hoffmann-La Roche Ltd., are a happy lot because they were successful in procuring the patent from Chennai branch of the office of Controller General of Patents, Designs & Trade Marks (CGPDTM) last year.
In 2005-06, the CGPDTM granted a staggering 4,320 patents – an increase of 125% over the 2004-05 figures. However, despite such impressive figures, the Indian patent rights organisation is being blamed from various quarters for being anything but transparent and reliable. “There are far too many problems associated with the whole process of getting your product patented in India. The procedural hassles eat into your time and the lack of openness in the system certainly raises doubts in the minds of the inventors. Furthermore, it is most disturbing when you have to run from pillar to post to get things done,” Dr. Subodh Sharma, a noted Pune based pharmacologist, who has been engaged in the process of drug registration for many years shared his views with B&E. Dr. Subodh’s view’s have been corroborated recently by the National Knowledge Commission.
The commission under the stewardship of Sam Pitroda has recommended Prime Minister Manmohan Singh to bring about some sweeping changes in the standard operating procedures being followed at the patents offices across India. The commission has unequivocally urged the government to introduce a fresh lease of life into Indian Intellectual Properties offices by making them more technology friendly. The commission feels that this needs to be implemented at an expeditious pace, because transparency needs to be introduced into the system and fair play ensured so that the competitors who raise objections against a particular application for patents get the feel that the system is fair to all.
Novartis AG may be unhappy with the Indian patents’ regime for refusing to grant patent rights to its cancer drug, Gilvec, but many others like the Swiss drug company, F. Hoffmann-La Roche Ltd., are a happy lot because they were successful in procuring the patent from Chennai branch of the office of Controller General of Patents, Designs & Trade Marks (CGPDTM) last year.
In 2005-06, the CGPDTM granted a staggering 4,320 patents – an increase of 125% over the 2004-05 figures. However, despite such impressive figures, the Indian patent rights organisation is being blamed from various quarters for being anything but transparent and reliable. “There are far too many problems associated with the whole process of getting your product patented in India. The procedural hassles eat into your time and the lack of openness in the system certainly raises doubts in the minds of the inventors. Furthermore, it is most disturbing when you have to run from pillar to post to get things done,” Dr. Subodh Sharma, a noted Pune based pharmacologist, who has been engaged in the process of drug registration for many years shared his views with B&E. Dr. Subodh’s view’s have been corroborated recently by the National Knowledge Commission.
The commission under the stewardship of Sam Pitroda has recommended Prime Minister Manmohan Singh to bring about some sweeping changes in the standard operating procedures being followed at the patents offices across India. The commission has unequivocally urged the government to introduce a fresh lease of life into Indian Intellectual Properties offices by making them more technology friendly. The commission feels that this needs to be implemented at an expeditious pace, because transparency needs to be introduced into the system and fair play ensured so that the competitors who raise objections against a particular application for patents get the feel that the system is fair to all. The applications need to be processed openly to obviate the doubts which may arise in the process.
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2008
Novartis AG may be unhappy with the Indian patents’ regime
for refusing to grant patent rights to its cancer drug, Gilvec, but many others like the Swiss drug company, F. Hoffmann-La Roche Ltd., are a happy lot because they were successful in procuring the patent from Chennai branch of the office of Controller General of Patents, Designs & Trade Marks (CGPDTM) last year.In 2005-06, the CGPDTM granted a staggering 4,320 patents – an increase of 125% over the 2004-05 figures. However, despite such impressive figures, the Indian patent rights organisation is being blamed from various quarters for being anything but transparent and reliable. “There are far too many problems associated with the whole process of getting your product patented in India. The procedural hassles eat into your time and the lack of openness in the system certainly raises doubts in the minds of the inventors. Furthermore, it is most disturbing when you have to run from pillar to post to get things done,” Dr. Subodh Sharma, a noted Pune based pharmacologist, who has been engaged in the process of drug registration for many years shared his views with B&E. Dr. Subodh’s view’s have been corroborated recently by the National Knowledge Commission.
The commission under the stewardship of Sam Pitroda has recommended Prime Minister Manmohan Singh to bring about some sweeping changes in the standard operating procedures being followed at the patents offices across India. The commission has unequivocally urged the government to introduce a fresh lease of life into Indian Intellectual Properties offices by making them more technology friendly. The commission feels that this needs to be implemented at an expeditious pace, because transparency needs to be introduced into the system and fair play ensured so that the competitors who raise objections against a particular application for patents get the feel that the system is fair to all.
Novartis AG may be unhappy with the Indian patents’ regime for refusing to grant patent rights to its cancer drug, Gilvec, but many others like the Swiss drug company, F. Hoffmann-La Roche Ltd., are a happy lot because they were successful in procuring the patent from Chennai branch of the office of Controller General of Patents, Designs & Trade Marks (CGPDTM) last year.
In 2005-06, the CGPDTM granted a staggering 4,320 patents – an increase of 125% over the 2004-05 figures. However, despite such impressive figures, the Indian patent rights organisation is being blamed from various quarters for being anything but transparent and reliable. “There are far too many problems associated with the whole process of getting your product patented in India. The procedural hassles eat into your time and the lack of openness in the system certainly raises doubts in the minds of the inventors. Furthermore, it is most disturbing when you have to run from pillar to post to get things done,” Dr. Subodh Sharma, a noted Pune based pharmacologist, who has been engaged in the process of drug registration for many years shared his views with B&E. Dr. Subodh’s view’s have been corroborated recently by the National Knowledge Commission.
The commission under the stewardship of Sam Pitroda has recommended Prime Minister Manmohan Singh to bring about some sweeping changes in the standard operating procedures being followed at the patents offices across India. The commission has unequivocally urged the government to introduce a fresh lease of life into Indian Intellectual Properties offices by making them more technology friendly. The commission feels that this needs to be implemented at an expeditious pace, because transparency needs to be introduced into the system and fair play ensured so that the competitors who raise objections against a particular application for patents get the feel that the system is fair to all. The applications need to be processed openly to obviate the doubts which may arise in the process.
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2008
An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative
Read these article :-
ZEE BUSINESS BEST B SCHOOL SURVEY
B-schooled in India, Placed Abroad (Print Version)
IIPM in Financial times (Print Version)
IIPM makes business education truly global (Print Version)
The Indian Institute of Planning and Management (IIPM)
IIPM Campus
Top Articles on IIPM:-
IIPM makes business education truly global-Education-The Times of ...
The Hindu : Education Plus : Honour for IIPM
IIPM ranked No.1 B-School in India, Management News - By ...
IIPM Ranked No1 B-School in India
Moneycontrol >> News >> Press- News >> IIPM ranked No1 B-School in ...
IIPM ranked No. 1 B-school in India- Zee Business Survey ...
IIPM ranked No1 B-School in India :: Education, Careers ...
The Hindu Business Line : IIPM placements hit a high of over 2000 jobs
Deccan Herald - IIPM ranked as top B-School in India
India eNews - IIPM Ranked No1 B-School in India
IIPM Delhi - Indian Institute of Planning and Management New Delhi ...
domain-b.com : IIPM ranked ahead of IIMs
Read these article :-
ZEE BUSINESS BEST B SCHOOL SURVEY
B-schooled in India, Placed Abroad (Print Version)
IIPM in Financial times (Print Version)
IIPM makes business education truly global (Print Version)
The Indian Institute of Planning and Management (IIPM)
IIPM Campus
Top Articles on IIPM:-
IIPM makes business education truly global-Education-The Times of ...
The Hindu : Education Plus : Honour for IIPM
IIPM ranked No.1 B-School in India, Management News - By ...
IIPM Ranked No1 B-School in India
Moneycontrol >> News >> Press- News >> IIPM ranked No1 B-School in ...
IIPM ranked No. 1 B-school in India- Zee Business Survey ...
IIPM ranked No1 B-School in India :: Education, Careers ...
The Hindu Business Line : IIPM placements hit a high of over 2000 jobs
Deccan Herald - IIPM ranked as top B-School in India
India eNews - IIPM Ranked No1 B-School in India
IIPM Delhi - Indian Institute of Planning and Management New Delhi ...
domain-b.com : IIPM ranked ahead of IIMs
contested the Lok Sabha by-election in 1997, necessitated by his father Biju Patnaik’s death, and was elected an MP. Soon after, he formed a new party, faced fresh polls and became a Cabinet Minister at the Centre and, later, the CM of Orissa, both in 2000 and 2004. On 26 December, 2007, his Biju Janata Dal (BJD) celebrated its 10th anniversary, which also marks Naveen’s completion of a decade in Orissa politics. His phenomenal rise is like a fairy tale. His journey from a writer to a wily politician is interesting. In 1985, his first book on Indian costumes, ‘A Second Paradise’ was launched and sold over 30,000 copies in America within a few days. In 2008, he is being called a truly ‘developmental’ CM.
boiling point. The Congress leader Sonia Gandhi is openly advocating the “merchants of death” theory to show the true colours of Chief Minister Narendra Modi. Modi on the other hand, is relentlessly pursuing his agenda to ensure that his Hindu vote bank backs him to the hilt in the ensuing elections to the state assembly. The Elections Commission has asked both the parties to explain their conduct during the election meetings.
Airlines was like a doting father giving away his daughter in marriage. She’s still a part of you, yet she is not with you,” says a remorseful Gorur Ramaswamy Iyengar Gopinath (Capt. G. R. Gopinath to you, and the man who made flying affordable to millions of Indian middle class). Under tremendous pressure and obviously bone tired, Gopinath had just emerged from another of those marathon 3-hour sessions with the Accenture team in Air Deccan’s Bangalore headquarters. Accenture is entrusted with the task of figuring out how best to bring about the synergies between the two merged airlines.
price of Rs.48 per share, there are confusing signals with respect to the de-listing of Essar Oil. On one hand, the company has confirmed on November 16 that it has given up its plan to de-list from the bourses. ‘To meet part of the requirement of funds for the expansion project and other corporate purposes, the board has approved the issue of GDS to promoters on a preferential basis, up to a maximum of $2 billion,’ the corporate stated. But this influx of shares would increase promoters’ stake to over 91% & to comply with SEBI guidelines, they necessarily must go for de-listing from the market. Clarity on this aspect is expected soon.
certainly not the IT hubs of modern day India. Yet for the residents of these villages, IT has brought in a welcome change. With the introduction of Biometric Smart Card (BSC), they have been spared the agony of being fleeced and cheated by middlemen, Panchayat leaders, or government officials, especially under NREG schemes. “I am able to keep a track of my attendance, work done, and payments received. Now, no one can cheat me as the BSC contains permanent records of all my transactions,” says a confident Subhash, a worker in Seelampur.
front can really pull down organisations. But virtualisation is one stupendously innovative technological concept that has made matters easier for all such companies. For the uninitiated, virtualisation is about hiding the true characteristics of resources and is one of the key concepts behind distributed network computing today.
the safest investment havens could not withstand the ongoing financial turmoil, the average Indian investor has never had it this good. With 34 mutual funds (MFs) lined up on dock, flaunting over 2,000 schemes to choose from, the mutual fund industry has unquestionably come a long way. However, the journey still appears to be petite when compared with global counterparts.
Adi Godrej tells us that he wants to have an incredible Rs.80 billion of this market by 2012. Can he manage even a significant part of it with the likes of HUL, P&G, ITC and many more having a killing hold on the market? Not unless Adi Godrej is ready to take corporate hits by the dozen. And M&As, like what Godrej is attempting of late [e.g. the takeover of UK hair dye manufacturer Rapidol] surely involve the highest risk – global research by McKinsey, BCG and the likes show that M&As destroy shareholder value on an average between 50 to 80%. COO Dr. Rakesh Sinha comments, “Godrej is looking for more such acquisitions for another five years.” Like we said, dangerous!
Maruti products lack the novelty factor which Hyundai and Tata Motors use quite successfully. Hyundai markets its cars as being exclusively for India. The i10, as well as other models, have been successfully branded through the ‘India first – the world later’ strategy. No Maruti product has ever been exclusively marketed solely for India. Here is where the concept A-Star enters, but more on that in later pages. Then, of course, is the threat from Tata’s supposed Rs.1 lac car, which according to market reports, will be marketed as ‘For India, By Indians’. The Tata car will also be sporting a diesel engine like its sibling Indica; clearly a direct threat to Maruti, more so because of the diesel premise. The Maruti top brass has been documented as having termed Tata’s small car ‘impractical’. Though I might agree, what if the Tata car does work out against all odds? Does Maruti have a Plan B that provides it flexibility to include further low-cost variants in its portfolio in case of a future fallout? Would it wish to include more diesel cars? I couldn’t get a clue...
the economy, with consumer spending for the month of Feburary up by a mere 0.1%. In contrast, Michael Brush, an award-winning New York financial writer, has quoted the movie attendance of Q1, 2008 to be up by 4.5% as compared to last year. “Movies offer something completely separate from what you are dealing with day to day. So they really become worth the money when money counts,” offers Jeff Blake, Vice Chairman, Sony Pictures Entertainment. The reasoning? As recession approaches people seek refuge from reality. Says Marino Marin, MD, Gruppo, Levey & Co., “Consumers cut back on purchases during recessions but shift discretionary spending money to affordable activities like movies.”
conscience that they exist. Talking about the most important challenge, Manav divulges, “If the operating cost increases, it only squeezes the market further. High ATF price is also a big challenge with ATF prices further set to increase globally by about 30-40% from the already alarming levels!” There is also the fact that while dealing with high income customers, recessionary consequences hit your business hard. But, Club One will have to live with this cyclical monster. The company’s slow addition to fleets may also sound logical, but the sudden boom in HNIs during India’s economic boom period may also mean unfulfilled demand. Challenges apart, ‘fractional ownership’ (a concept that Warren Buffet introduced with his chartered airlines business in America) for Indian businessmen has worked well for him. “We made a huge difference as there were not many HNIs who owned aircrafts except a few like the Tatas, Birlas and Ambanis. We take care of everything right from aircraft requirement to safety measures. You call us, say you want an aircraft and get it,” he points out.